Inventor

Marie-Pierre T. M. M. G. De Bethune

Inventor

Everberg, BE

Overview

15→

Patents

2001–2014

Patent span

Chemistry

Primary field (CPC C)

Patents· 15 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%

G01NInvestigating or analysing materials by determining their chemical or physical properties19%

C07DHeterocyclic compounds16%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms14%

C12NMicroorganisms or enzymes11%

Y02ATechnologies for adaptation to climate change8%

A61KPreparations for medical, dental or toiletry purposes5%

G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology5%

C07CAcyclic or carbocyclic compounds3%

PatentTitleYear

8,673,551'Methods, plasmid vectors and primers for assessing HIV viral fitness'2014 8,592,161'Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance'2013 8,076,062'Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance'2011 8,036,861'Method and means for determining the replication rate of a viral population'2011 7,935,710'Microbicidal pyrimidine or triazine for preventing sexual HIV transmission'2011 7,863,306'Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors'2011 7,659,404'Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors'2010 7,622,490'Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors'2009 7,595,334'Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors'2009 7,473,524'Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance'2009 7,429,677'Small molecule entry inhibitors'2008 7,244,752'Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors'2007 7,217,506'Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance'2007 6,528,251'Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains'2003 6,221,578'Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2014Based in Everberg, BE· patent location history

2007–2011Patents assigned to TIBOTEC PHARM LTD (10)· patent assignee history

2009–2014Patents assigned to DE BETHUNE MARIE-PIERRE T M M G (4)· patent assignee history

2009–2013Patents assigned to AZIJN HILDE (3)· patent assignee history

2009–2011Patents assigned to VINGERHOETS JOHAN HENDRIKA JOZEF (2)· patent assignee history

2011Based in Twee Leeuwenstraat, BE· patent location history

2013–2014Patents assigned to JANSSEN R & D IRELAND (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
TIBOTEC PHARM LTD	10	2007–2011
DE BETHUNE MARIE-PIERRE T M M Gself	4	2009–2014
AZIJN HILDE	3	2009–2013
JANSSEN R & D IRELAND	2	2013–2014
VINGERHOETS JOHAN HENDRIKA JOZEF	2	2009–2011

Locations

Location	Patents	Span
Everberg, BE	14	2001–2014
Twee Leeuwenstraat, BE	1	2011